Stockscreener 앱 받기
13.51
7.99%
1.00
시간 외 거래:
13.27
-0.24
-1.78%
Vor Biopharma Inc 주식(VOR)의 최신 뉴스
Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors - ts2.tech
Aug Chart Watch: Why Vor Biopharma Inc stock remains resilientPortfolio Performance Report & Free Technical Confirmation Trade Alerts - moha.gov.vn
Vor Biopharma Launches $150 Million Private Placement; Shares Rise - marketscreener.com
Vor Bio announces $150M private placement - MSN
Vor Bio Announces $150 Million Private Placement - Yahoo Finance
VOR shares rally over 40% in pre-market trade after JPMorgan initiates bullish coverage - MSN
Manufacturing Stocks To Keep An Eye OnDecember 9th - MarketBeat
Vor Biopharma (VOR) Is Up 45.6% After Telitacicept Phase 3 Win And JPMorgan Nod Has The Bull Case Changed? - Yahoo Finance
Vor Biopharma approves stock option repricing plan - MSN
Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR) - Seeking Alpha
Vor Biopharma (VOR): Valuation Check After Positive Telitacicept Phase 3 Data and Upbeat JPMorgan Coverage - Yahoo Finance
Vor Biopharma’s Recent Developments: Stock Impact Analyzed - StocksToTrade
Biotech stock soars 40% on JPMorgan’s bold call - Rolling Out
Vor Biopharma (VOR) Surges on J.P. Morgan's Bullish Outlook - GuruFocus
Vor Bio stock gains bullish view at J.P. Morgan (VOR:NASDAQ) - Seeking Alpha
Vor Biopharma (VOR) Stock Surges as JPMorgan Just Made a Massive Call on This Biotech - parameter.io
Vor Biopharma’s Telitacicept: A Promising Buy Amidst Valuation Disconnect and Strategic Focus on Unmet Needs - TipRanks
Vor Biopharma (VOR) Stock Explodes 40% as JPMorgan Sees Massive Upside Ahead - Blockonomi
Vor Biopharma Stock Surge: Strategic Move or Short-Lived Spike? - timothysykes.com
Vor Biopharma reprices stock options for employees and executives By Investing.com - Investing.com South Africa
Vor Biopharma (NASDAQ:VOR) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
Vor Biopharma Approves Stock Option Repricing Plan - TipRanks
Vor Biopharma reprices stock options for employees and executives - Investing.com
VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage - Stocktwits
JPMorgan Initiates Vor Biopharma at Overweight With $43 Price Target - marketscreener.com
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
JP Morgan Initiates Coverage on Vor Biopharma (VOR) with Overwei - GuruFocus
Vor Bio jumps as J.P.Morgan initiates with 'overweight' rating - TradingView
Vor Bio initiated with an Overweight at JPMorgan - TipRanks
JPMorgan initiates Vor Biopharma stock with Overweight rating, $43 target By Investing.com - Investing.com South Africa
JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential - Investing.com
JPMorgan initiates Vor Biopharma stock with Overweight rating, $43 target - Investing.com
JP Morgan Initiates Coverage of Vor Biopharma (VOR) with Overweight Recommendation - MSN
JPMorgan Starts Vor Biopharma, Inc. (VOR) at Overweight - StreetInsider
Profit Review: Will Vor Biopharma Inc stock maintain momentum in 2025 - moha.gov.vn
Vor Biopharma slumps 26%, prices $100M equity at $10 per share - MSN
Will Vor Biopharma Inc. stock maintain momentum in 2025Gold Moves & Capital Efficiency Focused Strategies - Newser
What drives Vor Biopharma Inc stock priceEarnings Surprise Analysis & Superior Capital Trading Plans - earlytimes.in
Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? - Yahoo Finance
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Form 424B3 Vor Biopharma Inc. - StreetInsider
Wedbush Predicts Vor Biopharma's Q4 Earnings (NASDAQ:VOR) - MarketBeat
How Vor Biopharma Inc. stock benefits from global expansionLayoff News & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Wedbush Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat
Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know - sharewise.com
Wedbush Initiates Coverage on Vor Biopharma (VOR) with Neutral R - GuruFocus
Wedbush Boosts Price Target on Vor Biopharma to $9 From $0.40, Keeps Neutral Rating - marketscreener.com
Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral - StreetInsider
Vor Biopharma Inc. (VOR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Vor Biopharma Inc. stock attract more institutional investorsWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Why retail investors favor Vor Biopharma Inc. stock2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
0.36%
1.05%
자본화:
|
볼륨(24시간):